Antigen-specific Engineered Immune Effectors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antigen-specific Engineered Immune Effectors, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors [Phase 1, Phase 2]